Co-Developing an HIV Prevention Program for Women in Ghana (NCT07003789) | Clinical Trial Compass
Active — Not RecruitingNot Applicable
Co-Developing an HIV Prevention Program for Women in Ghana
Ghana65 participantsStarted 2025-07-01
Plain-language summary
The WISE Woman Study is a research project in Ghana focused on improving HIV prevention among young women aged 18 to 35. In Ghana, young women are at higher risk of HIV but often lack access to the right information and services. This study will first work with young women and community partners to co-develop a youth-friendly and women-centered HIV prevention program. The program will focus on two proven strategies: HIV self-testing (HIVST) and pre-exposure prophylaxis (PrEP), a medicine that helps prevent HIV.
After the program is created, researchers will test it with 50 young women in Greater Accra and the Eastern Region to see if it's acceptable, easy to use, and if it helps increase knowledge and use of HIVST and PrEP. The intervention will be delivered through WhatsApp and community-based workshops to ensure privacy and reach. Participants will complete surveys and take part in discussions and interviews to share their feedback. This research will help build better HIV prevention strategies tailored to the needs of young women in Ghana.
Who can participate
Age range
18 Years – 35 Years
Sex
FEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Identify as female and be between 18-35 years of age
Reside in Greater Accra or the Eastern Region of Ghana
Be sexually active (defined as having engaged in vaginal, anal, or oral sex in the past 6 months)
Have access to a mobile phone with WhatsApp
Be willing to provide informed consent
Be interested in participating in HIV prevention activities
Be comfortable discussing sexual and reproductive health in a group setting (for the workshop)
For pilot phase only: must not have participated in the co-development workshop
Exclusion Criteria:
Do not reside in the two specified regions of Ghana
Unable to provide informed consent
Have cognitive impairments or severe mental health conditions limiting participation
Community partners with commercial conflicts of interest (for workshop only)
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Feasibility as Measured by FIM Score
Timeframe: Week 5 (end of intervention)
2
Acceptability as Measured by AIM Score
Timeframe: Week 5 (post-intervention)
3
Uptake of HIV self-testing (HIVST)
Timeframe: Baseline to Week 8
4
Willingness to Use PrEP (Survey-Based Behavioral Intention)